Half-top-hat wound configuration ideal

Article

A half-top-hat wound configuration is a valid option for penetrating keratoplasty (PK) as it offers better apposition of donor and recipient corneas, improved tectonic strength and the possibility of early suture removal.

A half-top-hat wound configuration is a valid option for penetrating keratoplasty (PK) as it offers better apposition of donor and recipient corneas, improved tectonic strength and the possibility of early suture removal, according to the findings of a study published in the January issue of the British Journal of Ophthalmology.

Igor Kaiserman, MD and colleagues from Toronto Western Hospital, Toronto, Canada described a new, more straightforward method of achieving the advantages of a lamellar wound configuration in PK.

The donor corneal button was prepared in a top-hat configuration, consisting of a central, full-thickness part 7 to 8 mm in diameter, surrounded by a peripheral lamellar wing of deep stroma and endothelium 0.5 mm in width. The recipient bed was prepared by a straight full thickness trephination with a suction trephine and the donor button was positioned by sliding the peripheral wing under the recipient bed. Sixteen 10-0 interrupted sutures and a single continuous 16-bite 11-0 sutures were placed. The interrupted sutures were passed so as to go through the wing, in order to ensure a good apposition of the wing to the inner corneal surface of the recipient.

A total of 10 eyes of 10 patients underwent the procedure. Mean follow-up time was 2.4 months, by which time the median visual acuity (VA) was 20/200 and the intraocular pressure (IOP) was 18.2 mmHg. No major intraoperative complications were noted and no postoperative events of graft rejection were recorded. One patient experienced a postoperative rise in IOP.

The authors of this report believe that the half-top-hat wound configuration offers a number of advantages for PK surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.